Tocqueville Asset Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,000
Closed -$232K 758
2018
Q3
$232K Buy
+2,000
New +$226K ﹤0.01% 751
2016
Q4
Sell
-31,365
Closed -$3.52M 815
2016
Q3
$3.52M Buy
31,365
+27,815
+784% +$3.2M 0.04% 343
2016
Q2
$440K Sell
3,550
-150
-4% -$18.1K 0.01% 658
2016
Q1
$416K Buy
+3,700
New +$384K 0.01% 668
2015
Q3
Sell
-30,085
Closed -$3.43M 970
2015
Q2
$3.43M Sell
30,085
-595
-2% -$72.1K 0.04% 378
2015
Q1
$3.21M Sell
30,680
-14,125
-32% -$1.5M 0.04% 390
2014
Q4
$5.39M Sell
44,805
-21,475
-32% -$2.82M 0.06% 301
2014
Q3
$9.7M Sell
66,280
-1,000
-1% -$154K 0.11% 204
2014
Q2
$11.2M Buy
67,280
+1,400
+2% +$249K 0.11% 207
2014
Q1
$13.1M Buy
65,880
+2,430
+4% +$459K 0.17% 151
2013
Q4
$12.1M Buy
63,450
+300
+0.5% +$55.8K 0.16% 159
2013
Q3
$10.7M Buy
63,150
+805
+1% +$125K 0.13% 188
2013
Q2
$9.46M Buy
+62,345
New +$8.83M 0.13% 191

Other funds holding CLB

Tocqueville Asset Management's CLB Position: Q4 2018 in Review

Tocqueville Asset Management sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 2,000 shares — an estimated $232K sold.

Tocqueville Asset Management first reported a position in CLB in Q2 2013 and held it in 13 quarters. The position peaked at $13.1M in Q1 2014. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

  • Tocqueville Asset Management reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
  • Tocqueville Asset Management sold 2,000 Core Laboratories shares in Q4 2018, an estimated $232K.
  • Tocqueville Asset Management first reported a position in Core Laboratories in Q2 2013 and held it in 13 quarters.
  • Tocqueville Asset Management's Core Laboratories position peaked at $13.1M in Q1 2014.
  • 320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Tocqueville Asset Management's 13F filing for Q4 2018, filed 8 Feb 2019.